Malignancy-associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation.
Many investigators worldwide are currently exploring the role of peripheral blood stem cell transplantation (PBSCT) in managing autoimmune diseases. We report the case of a woman with systemic lupus erythematosus (SLE) with mucocutaneous and renal involvement, who underwent PBSCT for stage IVB Hodgkin's disease. Following the development of the lymphoma, she has had a prolonged clinical and serologic remission of the SLE. The potential effects of lymphoproliferative disorders and PBSCT on the course of SLE are considered.
Schachna
L
L
Alfred Hospital, Prahran, Melbourne, Australia.
Ryan
P F
PF
Schwarer
A P
AP
D000293:Adolescent; D001804:Blood Transfusion, Autologous; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000150:complications* / Q000628:therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*